Prasun K. Jalal MD
Hepatology & Liver Transplantation
Stan and Sue Partee Chair in Hepatology, Abdominal Transplant Center, Baylor College of Medicine
Join to View Full Profile
6620 Main St.Suite 1450Houston, TX 77030
Phone+1 832-355-1400
Dr. Jalal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Prasun Jalal is a gastroenterologist in Houston, TX and is affiliated with multiple hospitals in the area, including Ben Taub General Hospital, Baylor St. Luke's Medical Center, and CHI St. Luke's Health-The Woodlands Hospital. He received his medical degree from Postgraduate Institute of Medical Education and Research, India and has been in practice 25 years. He specializes in hepatology & liver transplantation and is experienced in hepatology, non-alcoholic fatty liver disease, alcoholic liver disease, cirrhosis due to chronic viral hepatitis, and cirrhosis due to autoimmune hepatitis. He has more than 50 publications and over 500 citings.
Education & Training
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Gastroenterology, 2006 - 2007
Zucker School of Medicine at Hofstra/NorthwellFellowship, Gastroenterology, 2003 - 2006
Royal College of Physicians, London, United KingdomFRCP, 1996 - 2001- Postgraduate Institute of Medical Education and Research, IndiaClass of 1994, MD
Certifications & Licensure
TX State Medical License 2008 - 2026
American Board of Internal Medicine Gastroenterology- American Board of Internal Medicine Transplant Hepatology
Awards, Honors, & Recognition
- FRCP (London, UK), FACG, FASSLD, FASGE, AGAF
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012
Publications & Presentations
PubMed
- Corrected T1 (cT1) is the most appropriate diagnosis and monitoring tool for widespread adoption of resmetirom treatment in the United States.Marika Hancock, Cayden Beyer, Michael Fuchs, Mukesh Harisinghani, Prasun Jalal
Journal of Medical Economics. 2025-12-01 - Causes of mortality among patients with early-stage hepatocellular carcinoma.Karim Seif El Dahan, Darine Daher, Nicole E Rich, Anish J Nayak, Caroline Ankoma-Sey
Hepatology. 2025-07-22 - Blood bacterial DNA signatures in a prospective cohort of patients with MASLD cirrhosis.Suet-Ying Kwan, Lillian I Dolapchiev, Caren I Sanchez, Tiffany L Calderone, Jessica I Sanchez
Hepatology Communications. 2025-07-01
Press Mentions
Tapering Corticosteroids in Severe Alcohol-Associated Hepatitis Appears SafeNovember 28th, 2024
Heart Health Symposium Focuses on Asian Indian Risk of Heart Attacks and Its PreventionDecember 14th, 2017- IDA Hosts Fundraiser in Aid of Indian IDC Charity ClinicDecember 7th, 2017
Grant Support
- CROSSTALK BETWEEN GUT MICROBIOTA AND HEPATOCELLULAR CARCINOMA INDUCED BY METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASEBAYLOR COLLEGE OF MEDICINE2024–2026
- Intestinal Microbiota Transplantin Severe Alcohol associated HepatitisNatinal Institute of Health2022–Present
- Early Diagnosis of Liver CancerDora Roberts FoundationPresent
- MacDonald Research GrantBaylor St Luke Medical CenterPresent
Committees
- Education and Scholarship Committee, International Liver Transplantation Society
- Program Evaluation Committee, American Association for the Study of Liver Disease
Professional Memberships
- Fellow
- Fellow
- Fellow
- Member
- American Association for the Study of Liver DiseaseFellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
